Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer.

J Cancer · 2019 · PMC6400683 · PMID 30854118

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

While in Cohort 2, there was a strong trend toward worsen DFS with high ki67 by RT-PCR compared to Ki67 ≤5.68, with a p value of 0.053 (Table S2 ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.